The Procter & Gamble Company (NYSE:PG) Shares Sold by Meeder Advisory Services Inc.

Meeder Advisory Services Inc. decreased its stake in shares of The Procter & Gamble Company (NYSE:PG) by 1.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,492 shares of the company’s stock after selling 711 shares during the quarter. Meeder Advisory Services Inc.’s holdings in Procter & Gamble were worth $7,533,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after purchasing an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new stake in Procter & Gamble during the 3rd quarter worth $5,705,000. Welch Group LLC boosted its stake in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after purchasing an additional 2,990 shares during the period. GAMMA Investing LLC raised its position in Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the last quarter. Finally, Curi RMB Capital LLC raised its position in Procter & Gamble by 20.3% during the 3rd quarter. Curi RMB Capital LLC now owns 21,655 shares of the company’s stock worth $3,751,000 after buying an additional 3,652 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $169.12 on Monday. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The firm’s 50-day simple moving average is $170.32 and its 200 day simple moving average is $168.40. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock has a market cap of $398.28 billion, a P/E ratio of 29.23, a P/E/G ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The company’s revenue was down .6% on a year-over-year basis. Equities analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.38%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of analyst reports. TD Cowen initiated coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective for the company. DA Davidson upped their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research report on Monday, October 21st. Evercore ISI upped their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research note on Monday, September 30th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $177.00.

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the transaction, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. The trade was a 12.38 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 25.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 313,597 shares of company stock worth $53,268,499. 0.18% of the stock is owned by corporate insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.